Ferritin Quantitative Test

HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay)

HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Glycated hemoglobin A1c (HbA1c) concentration in human whole blood that contains EDTA or without anticoagulants samples, mainly used for the supervising of long-term glycemic control in diabetic individuals and auxiliary diagnosis of diabetes and identify patients at risk of diabetes.

Product Detail

Application

HbA1c is a product of the non-enzymatic chemical reaction between glucose and the N-terminus of the hemoglobin protein's β-chain (valine) amino groups. From a molecular biology perspective, HbA1c belongs to a diverse group of molecules termed advanced glycation end-products (AGEs).

 

In both diabetic and non-diabetic individuals, the relative levels of HbA1c reflect the duration and severity of hyperglycemic episodes, as well as the overall exposure to extracellular glucose present in the circulation. HbA1c levels, at varying cut-offs, have been developed as biomarkers for both the diagnosis of diabetes and the assessment of chronic glycemic control.

 

HbA1c reflects the average plasma glucose concentration over the previous 8 to 12 weeks. It can be measured at any time of the day and does not require special preparation, such as fasting. These properties have made HbA1c the preferred test for assessing glycemic control in people with diabetes.

 

More recently, there has been substantial interest in using HbA1c as a diagnostic test for diabetes and as a screening test for individuals at high risk of developing the condition. The use of HbA1c can avoid the problem of day-to-day variability in glucose values and eliminates the need for fasting and preceding dietary preparations. These advantages have important implications for the early identification and treatment of diabetes, which have been strongly advocated in recent years.

 

A persistently elevated level of HbA1c increases the risk of various vascular complications, such as coronary disease, heart attack, stroke, heart failure, kidney failure, blindness, erectile dysfunction, neuropathy, gangrene, gastroparesis, and short-term complications of surgery, including poor wound healing.

 

Product Specification

Sample Volume

WB: 10μL

Test Time

15 mins

Measuring Range

4.2-20%

Pack

20T40T100T

Storage

2~30

 

Features

Smart - Photosensitive and Luminescent Microspheres

Rapid - Whole Blood Sample Type Supported & No Centrifuge Needed

Convenient - Room Temperature Storage & Minimal sample consumption

 

Clinical significance

Diagnosis and Monitoring of Diabetes

Assessment of Long-Term Blood Glucose Control

Cardiovascular Risk Assessment

Medication Adjustment and Treatment Planning

Screening for Prediabetes

Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay)
C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay)
C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the C-peptide concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.
INS Rapid Quantitative Test (Chemiluminescence Immunoassay)
INS Rapid Quantitative Test (Chemiluminescence Immunoassay)
INS Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Insulin (INS) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.
FIA Analyzer
FLI-100 FIA Analyzer
The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.
biotime MAU Rapid Quantitative Test
MAU Rapid Quantitative Test
MAU(Microalbumin) occurs when the kidney leaks small amounts of albumin into the urine, which is an early marker of kidney damage.
Biotime PCT Rapid Quantitative Test
PCT Rapid Quantitative Test
PCT(Procalcitonin) is a peptide precursor of the hormone calcitonin. Measurement of PCT can be used as an authoritative marker for diagnosis and stratification of sepsis.
Biotime BNP Rapid Quantitative Test
BNP Rapid Quantitative Test
During heart failure, the heart makes two proteins, called B-type natriuretic peptide (BNP) and N-terminal-pro-BNP (NT-proBNP). Levels of both in the blood go up when heart failure gets worse and go down when it gets better.
Dengue NS1 Antigen Qualitative Rapid Test
Dengue NS1 Antigen Rapid Test
The Dengue NS1 Antigen Rapid Test is a lateral flow immunoassay for the qualitative detection of Dengue virus NS1 antigen in human serum, plasma or whole blood. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with the dengue virus. For professional in vitro diagnostic use only.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact